Inlet Private Wealth’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.63M | Sell |
14,421
-380
| -3% | -$81.8K | 0.88% | 38 |
|
|
2026
Q1 | $3.22M | Sell |
14,801
-1,600
| -10% | -$355K | 0.82% | 42 |
|
|
2025
Q4 | $3.75M | Sell |
16,401
-600
| -4% | -$137K | 0.87% | 40 |
|
|
2025
Q3 | $3.94M | Buy |
17,001
+47
| +0.3% | +$9.57K | 0.89% | 37 |
|
|
2025
Q2 | $3.15M | Hold |
16,954
| – | – | 0.77% | 41 |
|
|
2025
Q1 | $3.55M | Hold |
16,954
| – | – | 0.92% | 39 |
|
|
2024
Q4 | $3.01M | Buy |
16,954
+487
| +3% | +$89.5K | 0.8% | 44 |
|
|
2024
Q3 | $3.25M | Hold |
16,467
| – | – | 0.83% | 43 |
|
|
2024
Q2 | $2.82M | Buy |
16,467
+500
| +3% | +$82.8K | 0.77% | 42 |
|
|
2024
Q1 | $2.91M | Sell |
15,967
-10
| -0.1% | -$1.72K | 0.81% | 42 |
|
|
2023
Q4 | $2.48M | Sell |
15,977
-400
| -2% | -$58.3K | 0.76% | 41 |
|
|
2023
Q3 | $2.44M | Sell |
16,377
-13,047
| -44% | -$1.92M | 0.8% | 46 |
|
|
2023
Q2 | $3.96M | Buy |
29,424
+411
| +1% | +$60.3K | 1% | 30 |
|
|
2023
Q1 | $4.62M | Sell |
29,013
-300
| -1% | -$45.9K | 1.2% | 25 |
|
|
2022
Q4 | $4.74M | Sell |
29,313
-366
| -1% | -$56.1K | 1.22% | 23 |
|
|
2022
Q3 | $3.98M | Buy |
29,679
+401
| +1% | +$57.5K | 1.19% | 26 |
|
|
2022
Q2 | $4.48M | Sell |
29,278
-93
| -0.3% | -$14.2K | 1.28% | 24 |
|
|
2022
Q1 | $4.76M | Buy |
29,371
+215
| +0.7% | +$31.2K | 1.19% | 23 |
|
|
2021
Q4 | $3.95M | Buy |
29,156
+67
| +0.2% | +$7.91K | 0.96% | 39 |
|
|
2021
Q3 | $3.14M | Hold |
29,089
| – | – | 0.84% | 45 |
|
|
2021
Q2 | $3.28M | Buy |
29,089
+44
| +0.2% | +$4.96K | 0.86% | 46 |
|
|
2021
Q1 | $3.14M | Buy |
29,045
+2,019
| +7% | +$216K | 0.9% | 45 |
|
|
2020
Q4 | $2.9M | Buy |
27,026
+2,150
| +9% | +$207K | 0.95% | 40 |
|
|
2020
Q3 | $2.18M | Hold |
24,876
| – | – | 0.85% | 42 |
|
|
2020
Q2 | $2.44M | Buy |
24,876
+121
| +0.5% | +$10.7K | 0.97% | 39 |
|
|
2020
Q1 | $1.89M | Buy |
24,755
+2,300
| +10% | +$196K | 0.87% | 41 |
|
|
2019
Q4 | $1.99M | Buy |
22,455
+5,273
| +31% | +$438K | 0.66% | 46 |
|
|
2019
Q3 | $1.3M | Buy |
17,182
+2,000
| +13% | +$137K | 0.48% | 62 |
|
|
2019
Q2 | $1.07M | Buy |
15,182
+200
| +1% | +$15.7K | 0.38% | 72 |
|
|
2019
Q1 | $1.21M | Buy |
14,982
+7,100
| +90% | +$581K | 0.49% | 61 |
|
|
2018
Q4 | $727K | Buy |
+7,882
| New | +$693K | 0.39% | 63 |
|
Other funds holding ABBV
Inlet Private Wealth's ABBV Position: Q2 2026 in Review
Inlet Private Wealth reduced its AbbVie (ABBV) stake by 2.6% in Q2 2026, selling an estimated $81.8K and leaving 14,421 shares worth $3.63M. The position accounts for 0.88% of the portfolio, ranked #38.
Inlet Private Wealth first reported a position in ABBV in Q4 2018 and has held it in 31 quarters since. The position peaked at $4.76M in Q1 2022. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Inlet Private Wealth held 14,421 shares of AbbVie worth $3.63M as of Q2 2026.
- Inlet Private Wealth sold 380 AbbVie shares in Q2 2026, an estimated $81.8K.
- AbbVie made up 0.88% of Inlet Private Wealth's portfolio in Q2 2026, its #38 holding.
- Inlet Private Wealth first reported a position in AbbVie in Q4 2018 and has held it in 31 quarters since.
- Inlet Private Wealth's AbbVie position peaked at $4.76M in Q1 2022.
- 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Inlet Private Wealth's 13F filing for Q2 2026, filed 7 Aug 2026.